1. Stanković B, Trkuljić M, Balint B. Ispitivanje prevalence HBs antigen pozitivnih i anti-HCV reaktivnih dobrovoljnih davalaca krvi. Anestezija Reanimacija Transfuzija. 2006; 34 (1/2): 193-202;
2. Vasiljević N, Trkuljić M. Hematogene transmisivne bolesti. In: Balint B, Trkuljić M. et al, editors. Osnovi transfuziologije. Beograd: Čigoja štampa; 2002. p. 435-70;
3. Haass KA, Sapiano MRP, Savinkina A, Kuehnert MJ, Basavaraju SV. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module. Transfus Med Rev. 2019; 33(2): 84-91. doi: 10.1016/ j.tmrv.2019.01.001. PMID: 30930009;
4. Taseski J, Balint B, Vasiljevic N, Andrić Z, Stanković B, Vučetić B, et al. Transfuzijski transmisivne bolesti. Bilt Transfuziol. 2004; 50 (1-2): 69-81;
5. Niederhauser C . [Transfusion-transmitted Infections: How Useful and Costly is Testing for new Infectious Disease Pathogens?]. Praxis (Bern 1994). 2018; 107 (9-10): 521-9. [Article in German]. doi: 10.1024/1661-8157/a002967. PMID: 29690842;